COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions.

Vaccines (Basel) · 2022 · PMC8879861 · PMID 35214744

Europe PMC DOI

hedged sentence

0.1980

closest p · 4.0× alpha

0.1980

boldest claim

The sentences

did not reach statistical significancep = 0.198not close (p > 0.1)

pMCD reactors trended towards lower baseline tryptase levels compared to pMCD non-reactors although this trend did not reach statistical significance (15.4 μg/L vs. 23.7 μg/L; p = 0.198).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.